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        Introduction 
  Ras proteins are small GTPases involved in the regulation of im-
portant cellular functions such as proliferation, differen  tiation, 
and apoptosis (  Malumbres and Barbacid, 2003  ). The activity of 
Ras depends on its association with guanine nucleotides, being 
inactive when bound to GDP and active when associated with 
GTP. Ras proteins have an intrinsic low GTPase activity that is in-
creased by GTPase-activating proteins. The activity of Ras is reg-
ulated by extracellular factors that activate receptor Tyr kinases 
and recruit guanine nucleotide exchange factors to the plasma 
membrane (PM), promoting the Ras-GDP to Ras-GTP conver-
sion, which induces a conformational change that allows associa-
tion of Ras with effectors, including Raf1, PI3K, or Ral  –  guanine 
nucleotide dissociation stimulator, that become activated. 
  At the PM, Ras isoforms have distinct locations, which 
depend on their guanine nucleotide status. Thus, in the GDP 
conformation, Harvey Ras (HRas) resides in cholesterol-rich 
 domains ( Roy et al., 1999 ;  Prior et al., 2001 ), whereas upon GTP 
loading, it is recruited to cholesterol-poor domains. In contrast, 
GDP  –  neuroblastoma Ras (NRas) is resident in cholesterol-poor 
domains and moves to cholesterol-rich domains when loaded 
with GTP. Finally, Kirsten Ras (KRas)  –  GDP normally resides 
in cholesterol-poor domains, and no clear lateral segregation has 
been reported to occur after GTP loading. It is becoming evident 
that the differential Ras partitioning and nanoclustering within 
the PM infl  uence the generation and transmission of distinct sig-
nal outputs (  Hancock, 2003  ;   Tian et al., 2007  ). 
  The presence of HRas and NRas in the Golgi complex is 
not transient, and it has been shown that these isoforms are ac-
tive on this compartment (  Chiu et al., 2002  ;   Bivona et al., 2003  ; 
  Caloca et al., 2003  ;   Perez de Castro et al., 2004  ;   Quatela and 
Philips, 2006  ). In the majority of cell types, activation of Ras 
isoforms at the PM is fast and transient, whereas its activation at 
the Golgi is delayed and more sustained (  Chiu et al., 2002  ). 
However, it has been shown that stimulation of primary or Jurkat 
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Colocalization between both molecules was signifi  cantly in-
creased when cells were treated with EGF-TRITC for 20 min 
(  Fig. 1, B and C  ). Image magnifi  cation shows clear-cut colocal-
ization in both individual and clustered endosomes (  Fig. 1 D  ). 
  In vivo, time-lapse video confocal microscopy revealed 
colocalization of EGF-TRITC with GFP-KRas on EEs at differ-
ent times after EGF stimulation (  Video 1  ). Moreover, immuno-
cytochemical results also revealed colocalization among GFP-
KRas, EGF-TRITC, and the endogenous EGFR (  Fig. 1 E  ). 
Consistently, this was also confi  rmed in NIH3T3 cells (clone 
Wt8) stably expressing EGFR (  Fig. 1 F   and   Fig. S1, A and B  ). 
In NIH3T3-Wt8 cells treated with EGF, we also detected a sig-
nifi  cant increase of GFP-KRas and endogenous KRas together 
with the EGFR in the endosomal fractions isolated by sucrose 
gradients (  Fig. 1, G and H  , respectively). Endosomal fractions 
were prepared as described previously (  Grewal et al., 2000  ). 
Colocalization of endocytosed rhodamine-labeled transferrin 
with GFP-KRas on EEs was also observed (Fig. S1 C). These 
results indicate that a certain fraction of KRas localizes on EEs 
after EGF stimulation. 
  Endosomal translocation of KRas 
is independent of CaM and PKC 
phosphorylation 
  A recent study argued for a relevant role of CaM in the translo-
cation of PM-bound KRas to Golgi and endosomal membranes 
of hippocampal neurons stimulated by glutamate (  Fivaz and 
Meyer, 2005  ). Thus, we aimed to analyze the role of CaM in the 
regulation of KRas translocation to endosomes in COS-1 cells. 
We fi rst determined the presence of GFP-KRas on EEs in cells 
pretreated with the CaM antagonist, W13, for 1 h and subse-
quently stimulated with EGF (  Fig. 2 A  ). Under CaM-inhibitory 
conditions, we observed clear colocalization of KRas, EGF-
TRITC, and EEA1, suggesting that KRas localization on EEs 
was a CaM-independent process in this cellular type. 
 It has been reported that PKC phosphorylation on Ser181 
of KRas regulates its translocation to intracellular membranes 
(  Bivona et al., 2006  ;   Plowman et al., 2008  ). To study the effect 
of PKC phosphorylation on KRas translocation to endosomes, 
cells were treated with the general PKC inhibitor bisindolyl-
maleimide (BIM), and the presence of KRas on endosomes 
was analyzed. Results revealed a clear colocalization among 
KRas, EEA1, and EGF on intracellular vesicles, indicating 
that the translocation of KRas to EEs is a PKC-independent 
process (  Fig. 2 B  ). The endosomal distribution of the pseudo-
phosphorylated mutant YFP-KRas Ser181D or the nonphos-
phorylatable mutant YFP-KRas Ser181A after EGF treatment 
confi  rmed that translocation is independent of Ser181 phos-
phorylation (  Fig. 2, C and D  ). Although the KRas Ser181D 
mutant does not bind CaM, KRas Ser181A still retains this 
ability (  Lopez-Alcala et al., 2008  ). We observed that KRas 
Ser181A translocates to endosomes in the presence of W13 
( Fig.  2  E ),  confi  rming that KRas translocation to endosomes is 
CaM independent. Interestingly, EGF stimulation increases 
the relative colocalization of KRas (wild-type and Ser181 mu-
tants) with EEA1 in all of the aforementioned conditions (see 
quantifi  cations in   Fig. 2  ). 
T cells induced Ras activation exclusively on the Golgi, and 
there, activation is dependent on Ca 
2+ ,  phospholipase  C  ,  and 
the guanine nucleotide exchange factor RasGPR1 (  Bivona et al., 
2003  ;   Caloca et al., 2003  ;   Perez de Castro et al., 2004  ). HRas 
targeted to the Golgi apparatus or to the ER retained its full 
transforming activity, indicating that the signaling required for 
transformation can also be initiated from internal membranes. 
However, the signaling pathways activated in each case are 
slightly different (  Chiu et al., 2002  ). Thus, Ras signal outputs 
are determined to some extent by the intracellular location from 
which signaling arises. 
  It has been shown that Ras can activate endocytosis by di-
rectly regulating the Rab5 nucleotide exchange activity of RIN1 
(  Tall et al., 2001  ). Ras has also been found in the endocytic 
compartment (  Pol et al., 1998  ;   Howe et al., 2001  ;   Jiang and 
Sorkin, 2002  ;   Roy et al., 2002  ;   Fivaz and Meyer, 2005  ;   Gomez 
and Daniotti, 2005  ;   Jura et al., 2006  ). 
  The transit of Ras from PMs to endosomes has been well 
documented for the HRas isoform (  Jiang and Sorkin, 2002  ;   Roy 
et al., 2002  ;   Gomez and Daniotti, 2005  ;   Jura et al., 2006  ); HRas 
colocalizes with EGF receptor (EGFR) on early endosomes 
(EEs), where it engages Raf1 and triggers signaling activity. It 
has also been reported that endocytosis is required for maximal 
HRas signal output (  Roy et al., 2002  ). In contrast, KRas is less 
retained on endosomes, probably as a result of a faster recycling 
to the PM (  Jiang and Sorkin, 2002  ;   Roy et al., 2002  ). HRas 
and NRas can be ubiquitylated, which stabilizes their inter-
action with endosomal membranes. KRas is refractory to ubiqui-
tylation (  Jura et al., 2006  ). 
 KRas  specifi  cally interacts with CaM (  Villalonga et al., 
2001  ). In rat hippocampal neurons stimulated by glutamate, 
KRas recruits Ca 
2+  /CaM to the PM, inducing its translocation to 
Golgi and endosomal membranes (  Fivaz and Meyer, 2005  ). In-
terestingly, KRas can also be translocated from the PM to the 
ER, Golgi apparatus, and the outer mitochondrial membrane 
(  Bivona et al., 2006  ) by a PKC-mediated phosphorylation 
mechanism. On mitochondria, KRas associates with Bcl-Xl and 
induces apoptosis. 
  Several crucial aspects of the intracellular traffi  cking and 
signaling of KRas remain unclear. In this study, we have ana-
lyzed in detail and for the fi  rst time in vivo the traffi  cking of 
KRas from the PM along the endosomal compartment. The re-
sults reported in this study reveal that KRas is internalized 
through a clathrin-dependent mechanism and is transported 
along EEs, late endosomes (LEs), and eventually into lysosomes. 
KRas is active on the LE and together with the p14  –  MP1 scaf-
folding complex constitutes an intracellular signaling platform. 
  Results 
  Localization of KRas on the early 
endosomal compartment 
  GFP-KRas was transiently transfected in COS-1 cells, and its 
presence on endosomes was analyzed by confocal microscopy. 
For all purposes, we chose only cells with similar moderate lev-
els of KRas expression.   Fig. 1 A   shows that GFP-KRas colocal-
ized with the early endosomal marker EEA1 in starved cells. 865 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
  KRas follows the clathrin-dependent 
endocytic pathway upon EGF stimulation 
  Next, we focused on the mechanisms by which KRas is endo-
cytosed. Therefore, we examined whether the clathrin-dependent 
endocytic system could be involved in KRas endosomal translo-
cation.   Fig. 3 A   shows the presence of GFP-KRas in clathrin-
  Figure 1.       EGF induces KRas translocation to the early endosomal compartment.   COS-1 cells were transiently transfected with GFP-KRas, and its intracel-
lular localization was analyzed by confocal microscopy. (A) Colocalization of GFP-KRas and EEA1 on intracellular structures. (B) Cells treated with 100 
ng/ml EGF-TRITC for 20 min show increased colocalization between GFP-KRas, EEA1, and EGF-TRITC. (C) Quantiﬁ  cation of cells in B. Statistical signiﬁ  -
cances of differences between control and EGF treatment were determined using the Student  ’  s   t   test. Data are means   ±   SEM; **, P   <   0.01. (D) A more 
detailed confocal image of early endosomal structures positive for GFP-KRas, EEA1, and EGF-TRITC is shown. Red dotted circles indicate the perimeter of 
magniﬁ  ed endosomes. (E) Likewise, in EGF-stimulated cells, endocytosed EGFR detected by immunoﬂ  uorescence colocalizes with GFP-KRas and EGF-TRITC. 
(F) NIH3T3-Wt8 cells treated with 100 ng/ml EGF-TRITC for 20 min also conﬁ  rmed colocalization of GFP-KRas, EEA1, and EGF-TRITC. (G) In NIH3T3 cells, 
a signiﬁ  cant increase of GFP-KRas together with EGFR is detected in endosomal fractions isolated by sucrose density gradients after EGF treatment (Western 
blot), and the results presented are representative of three independent experiments (graph). (H) Similarly, after EGF stimulation, subcellular fractionation 
by sucrose gradients using nontransfected NIH3T3-Wt8 cells shows enrichment of endogenous KRas and EGFR in endosome fractions (Western blot). 
Colocalization is indicated with white (merge) or red (separate channels) arrows. (A, B, E, and F) Dotted boxes deﬁ  ne the areas from which the corresponding 
insets were generated. Bars: (A, B, E, and F) 20   μ  m; (D) 500 nm.     
coated pits in starved cells. When cells were incubated with 
EGF-TRITC, the colocalization was increased (  Fig. 3 C  ).   Fig. 3 E   
shows that GFP-KRas colocalized with EGFR after 2.5 min of 
EGF-TRITC stimulation. 
  Incubation of EGF for 1 h at 4  °  C allows binding of the li-
gand to its receptor clustered in coated pits, but internalization JCB • VOLUME 184 • NUMBER 6 • 2009  866
  Enhanced localization of KRas on late 
endosomal membranes: effects of 
baﬁ  lomycin and U18666A 
  Because a certain pool of internalized EGFR is sorted from the 
EE to the late endocytic compartment preceding lysosomal deg-
radation, we aimed to test whether KRas could also follow this 
late endocytic route.   Fig. 4 A   confi  rmed the colocalization be-
tween EEA1 and KRas and shows a small fraction of KRas on 
Rab7-positive LEs. 
  To improve the detection of KRas on the late endocytic 
compartment, cells were treated with U18666A, a molecule that 
inhibits cholesterol transport and alters the traffi  cking of multi-
vesicular body (MVB)  –  associated membrane proteins (  Liscum 
and Faust, 1989  ;   de Diego et al., 2002  ), or with bafi  lomycin-A1 
(B-A1), an inhibitor of vacuolar-type H 
+ -ATPase  that  blocks 
acidifi  cation and protein degradation in lysosomes (  van Weert 
et al., 1995  ;   Recchi and Chavrier, 2006  ). In COS-1 cells, both 
remains blocked (  Jiang et al., 2003  ). Thus, after 1 h at 4  °  C, 
clathrin detection was performed on starved COS-1 cells express-
ing GFP-KRas (  Fig. 3 B  ) or on EGF-TRITC  –  stimulated cells 
(  Fig. 3 D  ). Results showed some colocalization of clathrin with 
KRas in nonstimulated cells and an enhanced colocalization of 
clathrin with KRas and EGF in small punctate structures, corre-
sponding to coated pits. 
 The possibility that a clathrin-dependent mechanism could 
participate in the KRas endosomal translocation was investi-
gated in cells transfected with a dynamin-1 mutant (DynK44A) 
that blocks clathrin- and caveolae-mediated endocytosis ( Damke 
et al., 1994  ;   Oh et al., 1998  ). In cells expressing this mutant, 
EGF endocytosis was greatly reduced (  Fig. 3 F  ), and the co-
localization of KRas and EEA1 was signifi  cantly diminished 
( Fig.  3  G ).  These results together with the clear colocalization 
of KRas and clathrin revealed that KRas internalization is 
mainly mediated through a clathrin-dependent mechanism. 
  Figure 2.       Translocation of KRas to the early endosomal compartment is a CaM- and PKC-independent process.   COS-1 cells expressing GFP-KRas or the in-
dicated mutants were treated with EGF-TRITC for 20 min, ﬁ  xed, and immunolabeled with anti-EEA1. (A) Colocalization of GFP-KRas (wild type [wt]), EEA1, 
and EGF-TRITC on intracellular vesicles was observed after treatment with 10   μ  g/ml of the CaM inhibitor W13 for 1 h. (B) The same as in A but using 
10   μ  M of the general PKC inhibitor BIM for 1 h. (C) YFP-KRas (Ser181D [S181D]) colocalizes with EEA1 and EGF-TRITC. (D) Similarly, YFP-KRas (Ser181A 
[S181A]) colocalizes with EEA1 and EGF-TRITC. (E) The presence of YFP-KRas (Ser181A) on EEs was analyzed in cells treated with W13. Quantiﬁ  cation 
of colocalization is shown underneath each panel. Statistical signiﬁ  cances of differences between control and EGF treatment were determined using the 
Student  ’  s   t   test. Data are means   ±   SEM; **, P   <   0.01; ***, P   <   0.001. Colocalization is indicated with white (merge) or red (separate channels) arrows. 
Dotted boxes deﬁ  ne the areas from which the corresponding insets were generated. Bars, 20   μ  m.     867 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
  Figure 3.       KRas follows the clathrin-dependent endocytic pathway upon EGF stimulation.   (A  –  G) COS-1 cells were transiently transfected with GFP-KRas, and 
its intracellular localization was analyzed by confocal microscopy. (A) Starved cells were ﬁ  xed and immunolabeled with an anticlathrin antibody. (B) Clathrin 
detection on starved cells after 1 h at 4  °  C. (C) Cells treated with EGF-TRITC for 2.5 min were ﬁ  xed and immunolabeled with an anticlathrin antibody. The red 
dotted lines point to colocalization in the image and in the z-axis proﬁ  le. (D) The same as in C, but cells were incubated with EGF-TRITC for 1 h at 4  °  C. Recon-
struction of the z-axis proﬁ  le was performed to conﬁ  rm the visualization on basal PM (C and D, insets). (E) Cells treated with EGF-TRITC for 2.5 min were ﬁ  xed 
and immunolabeled with anti-EGFR. (F) Cells coexpressing GFP-KRas and the HA-tagged dynamin mutant K44A (DynK44A) were treated with EGF-TRITC for 
20 min and immunolabeled with anti-HA. Red dotted contours indicate the perimeter of cells cotransfected with GFP-KRas and HA-DynK44A. (G) Quantiﬁ  cation 
of EEA1 and GFP-KRas colocalization in control and dynamin K44A  –  expressing cells   ±   EGF is shown. Statistical signiﬁ  cances of differences between control 
and EGF treatment were determined using the Student  ’  s   t   test. Data are means   ±   SEM; **, P   <   0.01; ***, P   <   0.001. (A  –  E) Colocalization is indicated with 
white (merge) or red (separate channels) arrows. Dotted boxes deﬁ  ne the areas from which the corresponding insets were generated. Bars, 20   μ  m.     JCB • VOLUME 184 • NUMBER 6 • 2009  868
staining confi  rmed the accumulation of cholesterol in KRas-
positive LEs after U18666A treatment (Fig. S2 C). 
  Lysosomal targeting of KRas 
  Because KRas was detected on LEs, we aimed to study whether 
it may be targeted to the lysosomal compartment. In COS-1 
cells, GFP-KRas colocalized to some extent with EGF-TRITC 
and the lysosomal marker LAMP1 (  Fig. 5 A  ). We also analyzed 
KRas intracellular distribution in the presence of B-A1 or the 
lysosomal protease inhibitor leupeptin. In both cases, the intra-
cellular colocalization of KRas with LAMP1 was signifi  cantly 
increased (  Fig. 5, B  –  D  ). The same extent of colocalization was 
also obtained for LAMP2 (not depicted) or cathepsin D (see 
  Fig. 8 D  ). The accumulation of KRas on the endolysosomal 
compartment was confi  rmed in different cell types treated with 
drugs greatly enhanced accumulation of GFP-KRas and also the 
constitutively active mutant KRasG12V (not depicted) on enlarged 
endosomal structures (1  –  4   μ  m in diameter;   Fig. 4, B and D  ). The 
B-A1  –  induced phenotype was also studied in living cells ex-
pressing GFP-KRas (  Fig. S2 A  ). As KRas has also been found 
on mitochondria (  Bivona et al., 2006  ;   Plowman et al., 2008  ), we 
analyzed the possibility that the structures observed in B-A1  –
  treated cells were mitochondria instead of endosomes. In vivo 
staining with the MitoTracker probe revealed that despite a 
slight mitochondrial staining of KRas (Fig. S2 B), the fl  uores-
cence observed on endosomal membranes was largely higher. 
Moreover, the presence of two MVB/late endosomal markers 
(GFP-Rab7 and endogenous lysobisphosphatidic acid [LBPA]) 
on these enlarged vesicles further confi  rmed the late endosomal 
nature of such structures (  Fig. 4, C, E, and F  ). Finally, fi  lipin 
  Figure 4.       U18666A and baﬁ  lomycin  induce 
accumulation of KRas in a Rab7/LBPA late endo-
somal compartment.   (A) HA-KRas and GFP-
Rab7  –  expressing cells were treated with EGF for 
20 min and immunolabeled with an anti-HA (red 
channel) and anti-EEA1 (blue channel). Arrows 
indicate the colocalization of KRas and EEA1, 
and arrowheads point to Rab7-positive structures. 
(B) Localization of GFP-KRas in cells treated with 
U18666A. Arrows point to PM KRas labeling, and 
arrowheads show intracellular ringlike structures. 
(C) HA-KRas was coexpressed with GFP-Rab7 and 
treated with U18666A plus EGF for 45 min. Ar-
rows show colocalization of HA-KRas with GFP-
Rab7. (D  –  F) Localization of KRas in cells treated 
with 20 nM B-A1 overnight and with 100 ng/ml 
EGF for 45 min. Arrows indicate colocalization of 
HA-KRas and Rab7 (E) or GFP-KRas and LBPA (F) 
on enlarged endosomes. The white dotted contour 
in D indicates the cell perimeter, and the arrow-
heads point to ringlike endosomal structures. Bars: 
(A  –  D) 8   μ  m; (E and F) 2   μ  m.     869 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
The probe was properly targeted to late endosomal membranes 
as seen in B-A1  –  treated cells cotransfected with RFP-Rab7 
(Fig. S4 B). Also, upon EGF treatment, those LEs were labeled 
with the cotransfected EGFR  –  monomeric RFP (mRFP; Fig. S4 C). 
After 20  –  40 min of EGF stimulation, a high FRET effi  ciency of 
Raichu-KRas was observed on late endosomal membranes and 
also at the PM (  Fig. 6 A   and   Videos 3 and 4  ). As a negative con-
trol, we used a Raichu-Pak-Rho probe (  Yoshizaki et al., 2003  ), 
which did not show FRET effi  ciency on endosomal structures 
or at the PM (  Fig. 6 B   and   Videos 5 and 6  ). Results were plotted 
according to the endosomal relative FRET ratio values mea-
sured from both Raichu probes only on endosomal mem-
branes (  Fig. 6 C  ). The FRET effi  ciency of Raichu-KRas refl  ects 
the activation state of the molecule, thus concluding that KRas 
can be activated on these Rab7-positive structures (Fig. S4 D). 
Importantly, under these conditions endosomal fusion was still 
functional. Indeed, we observed GFP-KRas – positive vesicles har-
boring internalized EGF-TRITC undergoing endosomal fusion 
(  Fig. 6 D   and   Video 2  ). 
  Recruitment of Grb2 and Raf1 to 
KRas-positive LEs 
  It has been reported that Grb2 and Ras coordinately traffi  c during 
EGFR endocytosis (  Jiang and Sorkin, 2002  ). Thus, we examined 
the recruitment of Grb2 to the endolysosomal compartment 
where KRas is present. Under B-A1 conditions, starved cells 
overexpressing Grb2-YFP showed a diffuse cytoplasmic distribu-
tion (  Fig. 7 A  ). After 45 min of EGF-TRITC internalization, a 
high proportion of Grb2-YFP was effi  ciently redistributed to-
gether with the EGFR and its ligand to enlarged endocytic struc-
tures ( Fig. 7 B ). Nonstimulated cells cotransfected with CFP-KRas 
and Grb2-YFP only exhibited endosomal localization of KRas 
and EGFR (  Fig. 7 C  ). However, EGF stimulation induced a clear 
recruitment of Grb2 to KRas-positive endosomes harboring both 
the EGFR and ligand (  Fig. 7 D  ). 
  Finally, we investigated whether KRas present on the 
endolysosomal compartment was able to recruit Raf1. In non-
stimulated cells coexpressing YFP-Raf1 and CFP-KRas, the 
distribution of Raf1 was mainly cytosolic, although some de-
gree of colocalization with KRas-labeled vesicular structures 
could be identifi  ed (  Fig. 7 G  ). Importantly, upon EGF-TRITC 
stimulation, a striking recruitment of Raf1 to late endosomal 
membranes positive for LAMP1 was observed (  Fig. 7 H   and 
  Fig. S5 A  ). Under the same experimental conditions, when 
YFP-Raf1 was transfected alone, only a certain degree of co-
localization of Raf1 with EGF-TRITC could be detected after 
45 min of EGF endocytosis (  Fig. 7, E and F  ). These results 
demonstrated that KRas, on this endolysosomal compartment, 
is susceptible to being activated and capable for signaling. 
  KRas-mediated MAPK signaling on LEs 
  To further link KRas localization on LEs to an established sig-
naling pathway, we analyzed the possibility that KRas could be 
involved in the MAPK activation on LEs. It has been shown 
(  Wunderlich et al., 2001  ) that p14, a protein specifi  cally associ-
ated with the cytoplasmic leafl  et of the LE, interacts with the 
scaffold protein MP1, which assembles a scaffold complex in 
B-A1 (Fig. S2, D  –  G). In contrast, GFP-HRas was found to be 
mainly present on Golgi membranes (  Fig. 5, E and F  ). Similar 
data were obtained for GFP-NRas (  Fig. S3, A and B  ). 
 High  magnifi  cation confocal in vivo imaging enabled a 
more detailed analysis of the topology of KRas in those LEs. 
Interestingly, most of the GFP-KRas  –  expressing cells exhibited 
a variable number of MVB-like structures (in this study, we do 
not distinguish between different subpopulations of late endo-
somal compartments or MVBs) with a KRas staining on intra-
lumenal membranes ( Fig. 5 G ). Tomographic sectioning allowed 
3D reconstruction of such structures (  Fig. 5 H and H     ). Assum-
ing that the thickness of the optical section is a function of 
the pinhole diameter, wavelength, refraction index, and numerical 
aperture for a 488-nm excitation wavelength, the optical section 
resolution thickness is    470 – 500  nm.  Therefore,  the  size  of  the 
MVB-like structures analyzed was higher than 2  –  3   μ  m, and the 
mean intralumenal vesicle diameter was around 500 nm. 
  All of these results prompted us to study whether KRas 
targeted to this compartment could undergo lysosomal degrada-
tion. For this purpose, we monitored the stability of HA-tagged 
KRas in control or leupeptin plus B-A1  –  treated COS-1 cells 
  after EGF stimulation under experimental conditions according to 
published data (  Linares et al., 2007  ;   Fasen et al., 2008  ;   Hill 
et al., 2008  ). Results indicated that treated cells showed a signif-
icant increase in the stability of KRas as well as for the EGFR, 
which was used as a control (  Fig. 5 J   and Fig. S3 G). Similar re-
sults were obtained by [ 
35  S]Met metabolic labeling experiments 
(Fig. S3, I  –  K); data analysis from these experiments shows that 
after EGF stimulation, the half-life of HA-KRas was 3.3 h, 
whereas in the absence of stimulation, it was 5.4 h. When cells 
were treated with lysosomal inhibitors, the half-life in both con-
trol and EGF-stimulated cells was 5.1 h and 6.6 h, respectively. 
In contrast, no changes were detected in KRas stability upon treat-
ment with the proteasomal inhibitor MG132 (Fig. S3 H). 
  Finally, in an effort to detect the endogenous KRas on the 
endolysosomal compartment, GFP-Rab7  –  expressing COS-1 
cells were treated with B-A1 and then subjected to immunocyto-
chemical analysis using a pan-Ras antibody (because of the low 
labeling effi  ciency of the isoform-specifi  c antibodies). Results 
revealed a considerable colocalization between Rab7 and endo-
genous Ras (  Fig. 5 I  ). Under the same conditions but using non-
transfected cells, we confi  rmed the presence of endogenous Ras 
on vesicles containing endocytosed EGF-TRITC or the endoge-
nous lysosomal protease cathepsin D (Fig. S3, E and F). Thus, 
according to our results, we assume that the major isoform de-
tected by this antibody in this compartment was the endogenous 
KRas. Therefore, we show for the fi  rst time that upon EGF stim-
ulation, KRas is targeted to the lysosomal compartment, where 
it can be degraded. 
  Monitoring in vivo KRas activation on the 
endolysosomal system 
  We considered the possibility that the endolysosomal compart-
ment acts as a new platform for KRas activation. Therefore, ac-
tivation of KRas on LEs in B-A1  –  treated cells was measured 
by fl  uorescence recovery energy transfer (FRET) microscopy 
using the Raichu-KRas probe (  Fig. S4 A  ;   Kiyokawa et al., 2006  ). JCB • VOLUME 184 • NUMBER 6 • 2009  870
  Figure 5.       Lysosomal targeting of KRas.   (A) COS-1 cells expressing GFP-KRas were treated with 100 ng/ml EGF-TRITC for 2 h. Triple labeling of GFP-KRas, 
LAMP1 (blue channel), and EGF-TRITC (red channel) is shown, and arrows indicate colocalization. (B and C) GFP-KRas  –  expressing cells were treated either 
with 20 nM B-A1 (B) or 25   μ  M leupeptin (C) and EGF. Immunolabeling with anti-LAMP1 antibody shows colocalization of KRas (green channel) with LAMP1 
(red channel) on perinuclear ringlike structures (see arrows in insets of B and insets 1  –  3 of C); arrowheads (B, insets) point to KRas-positive vesicles not 
labeled with LAMP1. TO-PRO 3 is a nuclear marker (blue channel). (D) Quantiﬁ  cation of LAMP1/GFP-KRas colocalization from experiments shown in A  –  C. 
Statistical signiﬁ  cances of differences between different treatments were determined using the Student  ’  s   t   test. Data are means   ±   SEM; *, P   <   0.05; 
***, P   <   0.001. (E and F) GFP-HRas  –  expressing cells treated with B-A1 (E) or leupeptin (F) and EGF show colocalization of HRas (green channel) with 
GMAP210 (Golgi marker; blue channel) but not with LAMP1 (red channel). (G) In vivo imaging of GFP-KRas  –  expressing cells after treatment with B-A1, 
leupeptin, and EGF reveals MVB-like structures containing intralumenal GFP-KRas  –  positive membranes (z1  –  z12). (H and H    ) 3D tomographic reconstruction of 
confocal sections z1  –  z11 (H) and z1  –  z7 (H    ). (I) GFP-Rab7  –  expressing cells treated with B-A1 and EGF and labeled with anti  –  pan-Ras exhibit considerable 
colocalization (arrows). Arrowheads point to Rab7-positive vesicles not labeled with the pan-Ras antibody. (J) HA-KRas stability was measured in control 871 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
experiments with EGF. To determine the subcellular distribu-
tion of endogenous activated MAPK, we used an antibody that 
recognizes only the phosphorylated form of ERK1/2. Using 
confocal imaging, we analyzed the subcellular distribution of 
endogenous activated ERK1/2 in relation to the GFP-KRas/
p14-positive endosomes after 5, 10, 30, or 60 min of EGF 
stimulation. Starved nonstimulated cells showed no signifi  cant 
phospho-ERK1/2 (pERK1/2) staining ( Fig. 9 A ). However, after 
5 min of EGF stimulation, pERK1/2 staining could be detected 
the extracellular signal-regulated kinase (ERK) cascade, elicit-
ing a MAPK signal output from this intracellular compartment 
(  Wunderlich et al., 2001  ;   Teis et al., 2002  ,   2006  ). We found that 
 after 45 min of EGF stimulation, Xpress-tagged p14 or myc-tagged 
MP1 colocalized with GFP-KRas (  Fig. 8, A and C  ). This colocal-
ization became more evident after B-A1 or leupeptin treatment on 
ringlike cathepsin D    –    positive structures (  Fig. 8, B and D  ). 
  Next, we tried to study the kinetics of MAPK activation 
on the endolysosomal compartment by performing pulse-chase 
and B-A1 plus leupeptin  –  treated cells. Before stimulation with 100 ng/ml EGF, starved cells were preincubated for 6 h with 100   μ  g/ml CHX (control) or 
CHX in combination with B-A1 plus leupeptin (B-A1 + Leu). Equal amounts (15   μ  g) of cell lysates from 0, 3, 6, 15, and 21 h after EGF addition were 
electrophoresed, and the levels of HA-KRas detected with an anti-HA antibody in both control and B-A1 plus leupeptin  –  treated cells are shown (Western 
blot;   n   = 5). Actin was used as a loading control. Quantiﬁ  cation analysis by densitometry was performed. Data are the mean   ±   SEM; *, P   <   0.05; 
**, P   <   0.01 (Student  ’  s   t   test). Bars: (A  –  C, E, F, and I), 20   μ  m; (G, H, and insets) 2   μ  m.     
 
  Figure 6.       Time-lapse recording of KRas activation on the late endosomal compartment.   (A and B) COS-1 cells were transfected with Raichu-KRas (A) or 
Raichu-Pak-Rho (B). Starved cells were treated with 20 nM B-A1 overnight and then with 100 ng/ml EGF for 50 min. In the top panels, representative ratio 
images of YFP/CFP at the indicated time points after EGF stimulation are shown. In the bottom panels, representative images of CFP  –  Raichu-KRas (A) and 
CFP  –  Raichu-Pak-Rho (B) indicate localization of the probes at each corresponding FRET image frame. All images in A and B were obtained every 5 min 
with a time-lapse epiﬂ  uorescent microscope. High FRET efﬁ  ciency can be observed at the PM (arrowheads) and on endosomal structures (arrows) between 
25 and 45 min in Raichu-KRas  –  expressing cells only. (C) Quantiﬁ  cation of FRET (FRET ratio of YFP/CFP) efﬁ  ciency on the endocytic structures from at least 
six independent experiments was plotted for each time point by measuring the increase over the basal activity, which was averaged over 10 min before 
EGF addition. (D) Time-lapse video microscopy of COS-1 cells expressing GFP-KRas treated with B-A1 and with 100 ng/ml EGF-TRITC for 1.5 h. Confocal 
section images were collected every 15 s. Endosomal fusion of KRas-positive vesicles (green channel) harboring internalized EGF (red channel) is observed 
(arrows). Arrowheads point to PM-localized EGF-TRITC. Endosomal diameters d1 and d2 are 2.6   μ  m and 3.4   μ  m, respectively. Data are means   ±   SEM. 
Bars: (A and B) 20   μ  m; (D) 2   μ  m.     JCB • VOLUME 184 • NUMBER 6 • 2009  872
with the lysosomal inhibitors. However, in nontransfected cells, 
no signifi  cant sustained MAPK activation was observed (Fig. S5, 
B and C). Finally, we observed that the KRas-positive endosomal 
structures, in which endogenous pERK was detected, colocalized 
with endocytosed EGF-TRITC and the LysoTracker probe (  Fig. 9, 
H and I  ). Thus, the major stability of KRas and the more sustained 
activation of ERK1/2 in cells treated with lysosomal inhibitors 
suggest that endosomal KRas-mediated MAPK signaling can 
be down-regulated in later stages of the endocytic pathway. 
  Discussion 
  The results presented in this study indicate that KRas trans-
locates from the PM to the early and late endocytic compartment 
at certain domains of the PM and some nuclei (  Fig. 9 B  ). At this 
time point, no colocalization of pERK1/2 and KRas/p14-positive 
endosomes was observed. After 10 min of stimulation, the 
pERK1/2 signal was still observed at the PM, but partial stain-
ing could also be readily detected on GFP-KRas/p14-positive 
structures (  Fig. 9 C  ). Such colocalization became more evident 
after 30 min of stimulation (  Fig. 9 D  ). Even after the 60-min 
chase period, some cells still maintained the endosomal colo-
calization of pERK1/2, GFP-KRas, and p14 (  Fig. 9 E  ). 
  We also performed biochemical analysis of ERK1/2 acti-
vation in control and leupeptin plus B-A1  –  treated COS-1 and 
NIH3T3-Wt8 cells expressing HA-KRas (  Fig. 9, F and G  ). The 
relative activation of ERK1/2 was analyzed by densitometry ( Fig. 9, 
F and G  , graphs), revealing a sustained signaling in cells treated 
  Figure 7.       Grb2 and Raf1 are recruited to KRas-positive LEs.   (A and B) COS-1 cells were transfected with Grb2-YFP and treated with B-A1 for 6 h. (A) Starved 
cells show diffuse cytosolic distribution of Grb2-YFP. (B) After 45 min of EGF-TRITC stimulation, Grb2 is redistributed onto perinuclear vesicles. Colocalization 
of EGF-TRITC (red channel), immunolabeled EGFR (blue channel), and Grb2 (green channel) is observed (inset). (C and D) Grb2-YFP and CFP-KRas were co-
expressed in COS-1 cells, and then cells were treated with B-A1. (C) Control cells show diffuse cytoplasmic distribution of Grb2-YFP. Insets show colocalization of 
immunolabeled EGFR and CFP-KRas but not Grb2-YFP on both endosomes (arrows) and the PM (arrowheads). (D) After 45 min of EGF-TRITC stimulation, Grb2 is 
redistributed onto vesicular structures. Colocalization of EGF (red channel), immunolabeled EGFR (gray channel), Grb2 (green channel), and KRas (blue channel) 
is observed (arrows). (E and F) COS-1 cells were transfected with YFP-Raf1 and treated with B-A1 for 6 h. (E) Starved cells show diffuse cytoplasmic distribution 
of YFP-Raf1. (F) After 45 min of EGF-TRITC stimulation, Raf1 was recruited, to some extent, to vesicular structures (inset). Colocalization of internalized EGF (red 
channel) and Raf1 (green channel) could be observed (inset). (G and H) YFP-Raf1 and CFP-KRas were coexpressed in COS-1 cells, and then cells were treated with 
B-A1. (G) Control cells show a diffuse cytosolic pattern of YFP-Raf1. Some degree of colocalization of YFP-Raf1 (green channel) and CFP-KRas (blue channel) can be 
observed (white arrows in the merge inset and red arrows in the color channel insets). (H) After 45 min of EGF-TRITC stimulation, Raf1 is redistributed onto vesicular 
structures. Clear colocalization of endocytosed EGF (red channel), Raf1 (green channel), and KRas (blue channel) is observed (white arrows in the merge inset and 
red arrows in the color channel insets). (B  –  D and F  –  H) Dotted boxes deﬁ  ne the areas from which the corresponding insets were generated. Bars, 20   μ  m.     873 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
  KRas is internalized via a clathrin-
dependent pathway en route to the 
endocytic compartment 
  The localization of KRas on clathrin-coated pits and the abro-
gation of its internalization in cells expressing the dynamin 
through a clathrin-dependent pathway and independently of CaM 
and PKC phosphorylation. Then, from LEs, KRas is eventually 
targeted to lysosomes. FRET analysis using the Raichu-KRas 
probe shows that KRas is active on LEs and recruits Raf1 to 
elicit a MAPK signal output. 
  Figure 8.       KRas localizes on LEs containing the p14  –  MP1 
scaffolding complex.   (A and B) COS-1 cells transiently co-
expressing GFP-KRas and Xpress-tagged p14. (A) Colocaliza-
tion of KRas (green channel) with p14 (blue channel) and 
endocytosed EGF-TRITC (100 ng/ml for 45 min) on peri-
nuclear endosomes (insets). (B) Late endosomal colocalization 
of GFP-KRas and p14 after B-A1 treatment (20 nM for 6 h) 
in nonstimulated cells (insets). TO-PRO 3 is a nuclear marker 
(blue channel). (C and D) COS-1 cells were cotransfected with 
GFP-KRas and myc-tagged MP1. (C) Colocalization of KRas 
(green channel) with MP1 (blue channel) and endocytosed 
EGF-TRITC (red channel) on LEs (insets). (D) Triple labeling of 
GFP-KRas, MP1 (red channel), and cathepsin D (CatD; blue 
channel) is shown in cells treated with leupeptin for 8 h and 
EGF (100 ng/ml for 45 min; insets). Colocalization is indi-
cated with white (merge) or red (separate channels) arrows. 
Dotted boxes deﬁ  ne the areas from which the corresponding 
insets were generated. Bars, 20   μ  m.     JCB • VOLUME 184 • NUMBER 6 • 2009  874
  Figure 9.       KRas-mediated MAPK signaling on LEs.   (A  –  E) Cells coexpressing GFP-KRas with Xpress-tagged p14 were treated with 20 nM B-A1plus 25   μ  M 
leupeptin for 6 h and then were left starved or pulse-chase stimulated with 100 ng/ml EGF for various times before ﬁ  xation. Cells were then subjected 
to indirect immunoﬂ  uorescence analysis using anti-Xpress and anti-pERK1/2 antibodies. (A) The pERK1/2 antibody showed no staining in starved cells. 
KRas (green channel) colocalizes with p14 (blue channel)-positive endosomes (insets 1 and 2). (B) After 5 min of EGF stimulation, pERK1/2 labeling (red 
channel) can be readily detected on the PM (inset 3) and nuclei. Endosomal colocalization of KRas (green channel) and p14 (blue channel) is also shown 
(inset 4). (C  –  E) In cells that were stimulated with EGF for 10 (C), 30 (D), or 60 min (E), colocalization of pERK1/2 (red channel) with GFP-KRas and p14 
(blue channel) was detected on endosomal structures (insets 5  –  10). After 10 min of EGF stimulation, pERK1/2 labeling can also be observed on the PM 
(inset 5). Insets 1  –  10 show magniﬁ  cations of boxed areas. (F and G) COS-1 cells (F) and NIH3T3-Wt8 (G) cells were transiently transfected with HA-KRas 875 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
and serum starved for 20 h. Control cells or cells treated with the lysosomal inhibitors B-A1 plus leupeptin (B-A1 + Leu) were then stimulated with EGF by 
pulse and chase for the indicated times. Cell lysates were separated by SDS-PAGE and probed with the indicated antibodies (Western blot;   n   = 5). The 
graphs show a densitometric analysis of ERK1/2 relative activation. The pERK1/2 signals were normalized against the ERK1/2 signals. Data are the mean   ±   
SEM; *, P   <   0.05 (Student  ’  s   t   test). (H) B-A1  –  treated cells expressing GFP-KRas were stimulated with 100 ng/ml EGF-TRITC for 45 min before ﬁ  xation. 
Colocalization of KRas (green channel) with immunolabeled pERK1/2 (blue channel) and EGF (red channel) is observed on ringlike structures (insets). 
(I) Leupeptin-treated cells expressing GFP-KRas were loaded with LysoTracker red DND-99 and incubated in the presence of 100 ng/ml EGF at 37  °  C for 
45 min before ﬁ  xation. Colocalization of KRas (green channel) with immunolabeled pERK1/2 (blue channel) and LysoTracker (red channel) is observed on 
ringlike structures (insets). (H and I) Dotted boxes deﬁ  ne the areas from which the corresponding insets were generated. Bars, 20   μ  m.     
 
K44 mutant indicate that internalization of KRas takes place 
via a clathrin-dependent mechanism. It possibly occurs as a 
complex of signaling-related molecules in a similar mode as 
proposed by   Jiang and Sorkin (2002)  , in which YFP-HRas and 
CFP-Grb2 together with the EGFR converge on endosomes. 
GFP-KRas was found on EEs in both resting and EGF-stimulated 
COS-1 (  Fig. 1, A, B, and D  –  F  ), NIH3T3 (Fig. S1, A and B), 
or porcine aortic endothelial cells (not depicted), which is in 
agreement with previous studies (  Jiang and Sorkin, 2002  ;   Fivaz 
and Meyer, 2005  ;   Gomez and Daniotti, 2007  ). On this com-
partment, GFP-KRas was found together with internalized 
EGF and its cognate receptor. 
  In this study, we report that a fraction of KRas is continu-
ously endocytosed and sorted to LEs. Upon EGF stimulation, 
EGFR in complex with Grb2 is endocytosed and transported to 
LEs together with Grb2-binding proteins such as Sos, resulting 
in the activation of KRas on LEs. FRET detection kinetics of 
KRas activation on the late endosomal compartment is similar 
to that of the EGF-TRITC internalization. 
  Several studies indicated that KRas may be transported 
from the PM to intracellular compartments by diffusion mecha-
nisms that rely on electrostatic gradients driving the polybasic do-
main within the KRas membrane anchor region (  Fivaz and Meyer, 
2005  ;   Bivona et al., 2006  ;   Gomez and Daniotti, 2007  ). This 
mechanism is similar to that described for myristoylated Ala-rich 
C kinase substrate, a protein that traffi  cs from the PM to lyso-
somes (  Allen and Aderem, 1995  ). In this study, we demonstrate 
for the fi  rst time in vivo endosomal fusion of GFP-KRas  –  labeled 
endosomes, providing new evidence that a KRas membrane  –
 based  traffi  cking also exists. Altogether, all of this evidence indi-
cates that KRas translocation from the PM to endomembranes 
may proceed through different pathways, by diffusion or vesicu-
lar traffi  c (  Fig. 10  ). The selection of one of these pathways prob-
ably depends on the cellular type but also on the specifi  c stimuli 
and/or the intracellular destination (  Ashery et al., 2006  ). 
  In this study, we show that enlarged LEs of cells treated with 
lysosomal perturbing agents allowed the identifi  cation of KRas 
on the perimeter membrane as well as on intralumenal membranes 
morphologically resembling MVB structures. These results are in 
agreement with previous data showing that taxol-treated cells 
redistribute GFP  –  truncated KRas (a GFP-tagged KRas-specifi  c 
membrane anchor probe) to MVB-like structures (  Apolloni et al., 
2000  ). Moreover, a recent study demonstrates that proteins with 
cationic domains (like the KRas C-terminal polybasic motif) are 
preferentially recruited to phosphatidylserine-enriched organelles 
(such as endosomes or lysosomes;   Yeung et al., 2008  ). 
  Importantly, although KRas accumulates on/in Rab7/
LAMP1/cathepsin D/LysoTracker-positive structures, HRas and 
NRas remained excluded from this compartment, being mostly 
located on Golgi and the PM. Interestingly, a recent study 
showed that Ras levels are modulated after leupeptin treatment 
in an axin  –     -catenin – overexpressing  system,  suggesting  that 
lysosomal function may participate in the regulation of Ras 
protein levels (  Jeon et al., 2007  ). In this study, we show that 
HA-KRas stability is signifi  cantly decreased when cells are 
stimulated with EGF. Interestingly, in EGF-stimulated cells ex-
posed to lysosomal inhibitors, the half-life is increased. These 
results further support our model that EGF-induced traffi  cking 
of KRas leads to lysosomal degradation. 
  In vivo analysis of endosomal 
KRas signaling 
  Signaling at the late endocytic compartment has been demon-
strated. The EGFR as well as other receptor Tyr kinases colocal-
ize with signaling modules on endocytic compartments and can 
dictate different signal outputs from distinct subcellular loca-
tions (  Jiang and Sorkin, 2002  ;   Jiang et al., 2003  ;   Huang et al., 
2006  ;   Hisata et al., 2007  ;   Taub et al., 2007  ;   Valdez et al., 2007  ). 
Scaffold and adapter proteins organize these signaling modules. 
Three scaffold proteins, the kinase suppressor of Ras-1 (KSR1), 
similar expression to   fgf   genes (Sef), and MP1, are known to 
assemble ERK complexes on different intracellular compart-
ments. KSR1 regulates the formation of a MAPK signaling unit 
at the PM upon EGF stimulation (  Mor and Philips, 2006  ). Sef 
selectively localizes MAPK/ERK kinase (MEK)  –  ERK com-
plexes to the cytosolic face of the Golgi (  Torii et al., 2004  ). 
Finally, the MP1 scaffold forms a stable heterodimeric com-
plex with the adapter protein p14 and assembles an ERK cas-
cade on the LE ( Wunderlich et al., 2001 ). Endosomal localization 
of the p14  –  MP1 complex is required for the activation of ERK 
on these structures (  Lunin et al., 2004  ). However,   Jiang and 
Sorkin (2002)   showed FRET between CFP-HRas and YFP  –
  Ras-binding domain on endosomal membranes in vivo. Alto-
gether, these studies support the idea that traffi  c from the PM to 
the LE is connected with signaling events in the cell. 
  In this study, we report the targeting of KRas to late endo-
somal membranes, where it colocalizes with the p14  –  MP1 scaf-
folding complex and activates the ERK signaling cascade. In 
addition, by means of the Raichu-KRas probe, we report activa-
tion of KRas on LEs. Because the membrane-anchoring motifs 
of the intramolecular FRET probes in this study consist of the 
native KRas polybasic sequence and CAAX moiety, it is likely 
that these domains represent the minimal membrane-interacting 
requirement that targets KRas to late endosomal membranes. 
  The recruitment of Raf1 by KRas on LEs indicates that in 
this compartment, KRas actively mediates intracellular signal JCB • VOLUME 184 • NUMBER 6 • 2009  876
vectors (Clontech Laboratories, Inc.). The GFP-NRas vector was supplied 
by J. Miyazaki (Osaka University, Osaka, Japan;   Niwa et al., 1991  ). The 
HA-HRas vector (pCEFLHA) was provided by P. Crespo (Consejo Superior 
de Investigaciones Cient  í  ﬁ  cas, Santander, Spain). Plasmids for mRFP-Rab7 
and EGFR-mRFP have been described previously (  Itoh et al., 2005  ;   
Kawase et al., 2006  ). The EGFR-CFP, Grb2-YFP, and pEGFP-Rab7 vectors 
were supplied by A. Sorkin (University of Colorado, Denver, Denver, CO). 
The pEF  –  HA-KRas plasmid was obtained from R. Marais. KRas (Ser181A) 
and KRas (Ser181D) mutants were obtained by PCR with reverse or for-
ward oligonucleotides carrying the appropriate mutations. The Raichu-
KRas and Raichu-Pak-Rho probes used in this study have been developed 
previously (  Mochizuki et al., 2001  ;   Yoshizaki et al., 2003  ). The Xpress-
p14 and myc-MP1 constructs were a gift from L.A. Huber (Innsbruck Medi-
cal University, Innsbruck, Austria). 
  Antibodies and reagents 
  Mouse EGF, W13, U18666A, B-A1, and leupeptin were obtained from 
Sigma-Aldrich; BIM-I and anti  –  pan-Ras (ab-3; Ras10) antibody were ob-
tained from EMD. EGF-TRITC, rhodamine-transferrin, and the MitoTracker 
red and LysoTracker DND-99 probes were obtained from Invitrogen. 
Mouse monoclonal anti-EGFR (clone 225) and anti  –  clathrin heavy chain 
(  ×  22) antibodies were obtained from A. Sorkin and F.M. Brodsky (Uni-
versity of California, San Francisco, San Francisco, CA), respectively. 
The GMAP210 polyclonal antibody was supplied by R.M. Rios (Univers-
idad de Sevilla, Sevilla, Spain). Monoclonal antibodies to EEA1 and 
LAMP1 were obtained from Transduction Laboratories. The monoclonal 
antiactin antibody was obtained from ICN Pharmaceuticals, and the 
polyclonal antibodies against EGFR (clone 1,005), KRas (F234), Rab5, 
and cathepsin D were obtained from Santa Cruz Biotechnology, Inc. The 
pERK1/2 and ERK1/2 antibodies were purchased from Cell Signaling 
Technology. Monoclonal anti-GFP antibody was obtained from Assay 
Designs. Polyclonal and monoclonal anti-HA antibodies were obtained 
from Sigma-Aldrich and Roche, respectively. Peroxidase-labeled anti-
bodies and SDS-PAGE molecular weight markers were purchased from 
Bio-Rad Laboratories. Monoclonal anti-Xpress antibody was obtained 
outputs through specifi  c effectors. Interestingly,   Corey and 
Kelley (2007)   recently reported an elevated Ras activity in 
Niemann-Pick disease type C cells. Because Niemann-Pick disease 
type C cells contain aberrant LEs with morphological features 
similar to those shown in this study, we speculate that such Ras 
activation could be explained by an increased KRas accumula-
tion/activity on this aberrant late endosomal compartment. 
  Whereas a previous study (  Roy et al., 2002  ) showed that 
endocytosis was not necessary for KRas signaling, in this study, 
we demonstrate that in addition to a PM signal output, the LE can 
be envisaged as a novel KRas signaling platform. However, fur-
ther studies will be required to evidence the physiological role of 
KRas signaling on LEs as well as the cross talk between other 
signaling molecules (i.e., p14 and MP1) on this compartment. 
  Overall, this study sheds new light on the spatiotemporal 
control of Ras signaling, providing new clues on the distinctive 
behavior of Ras proteins in the cell and how endosomal traffi  c 
orchestrates this behavior. Thus, we propose the LE as a novel 
KRas signaling platform. From this compartment, KRas trig-
gers functional outputs while en route to lysosomes, where sig-
naling will be attenuated/down-regulated. 
  Materials and methods 
  Plasmids 
  HRas, KRas, and Raf1 cDNAs were provided by R. Marais (Institute of 
Cancer Research, London, England, UK) and subcloned into living color 
  Figure 10.       Model of the endosomal KRas trafﬁ  c and signaling.   EGF binding triggers endocytosis of the EGFR and downstream signaling molecules to the 
early endosomal compartment. There, Ras signaling modules settle to elicit signal outputs. HRas is ubiquitinated and is recycled back to the PM, whereas 
KRas is sorted en route to LEs/MVBs. Once there, KRas can be GTP loaded, thus being able to recruit effectors such as Raf1, which initiates the MAPK 
signaling cascade on this compartment. Finally, KRas down-regulation/degradation may occur in the late endosomal/lysosomal compartment. CCV, 
clathrin-coated vesicle.     877 KR  AS   SIGNALING ON LATE ENDOSOMES   • Lu et al. 
point lysate was obtained, and 100 ng/ml EGF was added in all of the re-
maining dishes. At 3, 6, 15, and 21 h after EGF, additional medium was 
removed, and cells were washed twice with cold PBS and then frozen at 
    80  °  C. Cells were lysed with lysis buffer (20 mM Tris-HCl, pH 7.5, 2 mM 
EDTA, 100 mM NaCl, 5 mM MgCl  2  , 1% Triton X-100, 5 mM NaF, 10% 
glycerol, and 0.5% 2-mercaptoethanol) containing protease and phospha-
tase inhibitors. Cleared lysates (10,000   g  ) were assayed for protein con-
centration, and 15   μ  g of protein was subjected to Western blot analysis 
using speciﬁ  c HA and actin antibodies. HA-KRas signal was determined by 
densitometry and normalized to the actin levels. Data were analyzed by 
a Student  ’  s   t   test. Alternatively, in some experiments, metabolic labeling 
using [ 
35  S]Met was performed. 
  Phospho-MAPK analysis 
  Pulse and chase experiments were performed using starved COS-1 cells 
nontransfected or transfected with HA-KRas. After 15 h of transfection, 
cells were stimulated by pulse chase with 100 ng/ml EGF at 37  °  C for the 
indicated times. Then, medium was removed, and cells were washed 
twice with cold PBS and frozen at     80  °  C. Cells were lysed with lysis buf-
fer (see previous section) containing protease and phosphatase inhibi-
tors. Cleared lysates (10,000   g  ) were assayed for protein concentration, 
and 15   μ  g of protein was subjected to Western blot analysis using anti-
MEK1/2, anti  –  phospho-MEK1/2, anti-ERK1/2, and anti-pERK1/2 anti-
bodies. The phospho-MEK1/2 and pERK1/2 signals were normalized 
against the MEK1/2 and ERK1/2 signals, respectively. Data were ana-
lyzed by a Student  ’  s   t   test. 
  Online supplemental material 
  Fig. S1 shows early endosomal localization of KRas. Fig. S2 shows that the 
LE to lysosome transition inhibitors induce accumulation of KRas in the late 
endosomal compartment. Fig. S3 provides further data on the lysosomal 
targeting and degradation of KRas. Fig. S4 depicts a schematic represen-
tation of the Raichu-KRas probe and shows in vivo localization of this probe 
in B-A1  –  treated cells together with data on the activation dynamics of KRas 
on LEs. Fig. S5 demonstrates that KRas recruits Raf1 to late endosomal 
membranes and also shows further data on the effect of lysosomal inhibi-
tors on MAPK signaling. Video 1 shows in vivo visualization of endosomal 
GFP-KRas after EGF stimulation. Video 2 shows live imaging of endosomal 
fusion of GFP-KRas  –  positive endosomes. Videos 3 and 4 show FRET imag-
ing of Raichu-KRas on LEs. Videos 5 and 6 show FRET imaging of Raichu-Pak-
Rho on LEs. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807186/DC1. 
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